Patient & Cancer Information | Clinical Trials | Available Trials | Colorectal

Colorectal Cancer

10

Page 1 of 1

Studies of in-vivo 5-fluorouracil pharmacokinetics, with and without bevacizumab in patients with liver metastases from adenocarcinoma of the colon Disease/Condition: Colon Cancer Principal Investigator: Howard S Hochster
A Phase 1, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of Ascending Doses of AZD4547 in Patients with Advanced Solid Tumor Malignancies Disease/Condition: Advanced Solid Cancers Principal Investigator: Howard S Hochster
Phase I/IIa First Time in Human study of GSK2636771 in subjects with advanced solid tumors Disease/Condition: Breast Cancer (ER, PR, and HER2 negative) \| Colorectal Cancer \| Endometrial Cancer \| Gastric Adenocarcinoma \| Glioblastoma Multiforme \| Head/ Neck Squamous Cell Carcinoma \| Melanoma \| Non-Small Cell Lung Cancer (NSCLC) \| Ovarian Cancer \| Prostate Cancer Principal Investigator: Roy Herbst
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients using ColoPrint Disease/Condition: Colon Cancer Principal Investigator: Vikram Reddy
Phase II-III study to Evaluate the Efficacy and Safety of T-DM1 versus. Taxane in HER-2 positive Gastric Cancer and Gastroesophageal Cancer Disease/Condition: Adenocarcinoma of the Gastroesophageal Junction \| Gastric Cancer Principal Investigator: Howard S Hochster
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Disease/Condition: Colorectal Cancer Principal Investigator: Howard S Hochster
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Disease/Condition: Colorectal Cancer Principal Investigator: Howard S Hochster
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients with Advanced Breast and Gastrointestinal Tumors Disease/Condition: Gastrointestinal Tumors \| Metastatic Breast Cancer Principal Investigator: Gina G Chung
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Disease/Condition: Adenocarcinoma of the Esophagus \| Adenocarcinoma of the Gastroesophageal Junction \| Stage IB Esophageal Cancer \| Stage IIA Esophageal Cancer \| Stage IIB Esophageal Cancer \| Stage IIIA Esophageal Cancer \| Stage IIIB Esophageal Cancer Principal Investigator: Bryan William Chang
Phase III Study of TAS-102 plus Best Supportive Care versus Placebo plus Best Supportive Care in Patients with Colorectal Cancer Disease/Condition: Colorectal Cancer Principal Investigator: Howard S Hochster
Randomized, double-blind, Phase II Study of FOLFOX/Bevacizumab with MetMAb versus Placebo as First-Line Treatment for Patients with Metastatic Colorectal Cancer Disease/Condition: Colorectal Cancer Principal Investigator: Howard S Hochster

Page 1 of 1